Theradiag
Develops and markets in-vitro diagnostic solutions for biotherapy monitoring.
ALTER | PA
Overview
Corporate Details
- ISIN(s):
- FR00140069U4 (+1 more)
- LEI:
- 969500CDG241WHIFL611
- Country:
- France
- Address:
- 14 RUE AMBROISE CROIZAT, 77183 CROISSY-BEAUBOURG
- Sector:
- Manufacturing
Description
Theradiag is a company that develops, manufactures, and markets in-vitro diagnostic (IVD) solutions, with a primary focus on theranostics. The company specializes in creating tools for monitoring biotherapies, which are treatments using substances derived from living organisms. Its core product line, Lisa-Tracker, is a range of kits designed to help clinicians measure the efficacy of biotherapies, particularly for patients with autoimmune diseases. This allows for the personalization of treatment and improved patient outcomes. In addition to its focus on biotherapy monitoring, Theradiag also maintains its activities in developing and distributing diagnostic tests for autoimmunity and oncogenetics. The company leverages its extensive experience to provide innovative diagnostic tools for clinicians and patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-01-16 07:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 294.1 KB | ||
| 2023-01-06 07:30 |
Informations privilégiées / Autres communiqués
|
French | 216.6 KB | ||
| 2023-01-06 07:30 |
Inside Information / Other news releases
|
English | 218.7 KB | ||
| 2023-01-04 17:45 |
Informations privilégiées / Autres communiqués
|
French | 170.8 KB | ||
| 2022-12-07 07:30 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 149.9 KB | ||
| 2022-12-07 07:30 |
Information et rapport sur gouvernement d'entreprise
|
French | 3.3 MB | ||
| 2022-11-04 17:45 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 169.8 KB | ||
| 2022-11-02 19:20 |
Informations privilégiées / Autres communiqués
|
French | 524.4 KB | ||
| 2022-10-27 18:46 |
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
|
French | 2.0 MB | ||
| 2022-10-27 18:08 |
Inside Information / Other news releases
|
English | 226.4 KB | ||
| 2022-10-27 18:08 |
Informations privilégiées / Autres communiqués
|
French | 237.1 KB | ||
| 2022-10-04 17:45 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 170.3 KB | ||
| 2022-09-30 17:40 |
Inside Information / Other news releases
|
English | 222.3 KB | ||
| 2022-09-30 17:40 |
Informations privilégiées / Autres communiqués
|
French | 228.0 KB | ||
| 2022-09-23 13:54 |
News releases during takeover bids / Takeover bids Other news releases
|
English | 223.2 KB |
Automate Your Workflow. Get a real-time feed of all Theradiag filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theradiag
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theradiag via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
